Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03995017
Title Rucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal Adenocarcinoma (RiME)
Acronym RiME
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Anwaar Saeed
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
KU Cancer Center Fairway Kansas 66205 United States Details
University of Kansas Cancer Center - CRC Fairway Kansas 66205 United States Details
University of Kansas Cancer Center - West Kansas City Kansas 66112 United States Details
The University of Kansas Cancer Center, Westwood Campus Kansas City Kansas 66205 United States Details
University of Kansas Cancer Center - Overland Park Overland Park Kansas 66210 United States Details
University of Kansas Cancer Center - North Kansas City Missouri 64154 United States Details
University of Kansas Cancer Center - Lee's Summit Lee's Summit Missouri 64064 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field